Status:
COMPLETED
EARLYEMOLLIENT - Feasibility of Early Emollient Use in Children With Atopic Eczema
Lead Sponsor:
University Hospital Schleswig-Holstein
Collaborating Sponsors:
Technische Universität Dresden
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
1-21 years
Phase:
NA
Brief Summary
The aim of this pragmatic, parallel group, assessor-blind randomised open-label prospective study is to determine the reasons that motivate parents to enrol or not enrol their child in a randomized, c...
Detailed Description
The aim of this trial is to determine the reasons that motivate parents to enrol or not enrol their child in a randomized, controlled basic emollient trial for the prevention of AE. Furthermore, this ...
Eligibility Criteria
Inclusion
- Participant (i.e. the newborn baby) must have a parent or sibling with a history of AE, allergic rhinitis or asthma.
- Infant in overall good health.
- Term-born babies
- Mother at least 18 years of age at delivery and capable of giving informed consent.
Exclusion
- Preterm birth (defined as birth prior to 37 weeks gestation).
- Previous child randomised to this trial.
- Major congenital anomaly.
- Significant inflammatory skin disease at birth (except seborrheic dermatitis).
- Any immunodeficiency disorder or severe genetic skin disorder.
- Any condition that would make the use of emollients inadvisable or not possible.
Key Trial Info
Start Date :
February 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03376243
Start Date
February 1 2017
End Date
June 1 2021
Last Update
September 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
USchleswig-Holstein
Kiel, Scheswig-Holstein, Germany, 24105